{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T22:26:37Z","timestamp":1779229597231,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,2,22]],"date-time":"2013-02-22T00:00:00Z","timestamp":1361491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-85","type":"journal-article","created":{"date-parts":[[2013,2,22]],"date-time":"2013-02-22T14:21:19Z","timestamp":1361542879000},"source":"Crossref","is-referenced-by-count":49,"title":["Use of \u00df-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study"],"prefix":"10.1186","volume":"13","author":[{"given":"Sigrun A","family":"Johannesdottir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric V","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Blumenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Lemeshow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,22]]},"reference":[{"key":"3717_CR1","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1136\/bmj.39185.440382.47","volume":"334","author":"HT Ong","year":"2007","unstructured":"Ong HT: Beta blockers in hypertension and cardiovascular disease. BMJ. 2007, 334: 946-949. 10.1136\/bmj.39185.440382.47.","journal-title":"BMJ"},{"issue":"9","key":"3717_CR2","first-page":"4514","volume":"9","author":"SK Lutgendorf","year":"2003","unstructured":"Lutgendorf SK, Cole S, Costanzo E, Bradley S, Coffin J, Jabbari S, Rainwater K, Ritchie JM, Yang M, Sood AK: Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res. 2003, 9 (9): 4514-4521.","journal-title":"Clin Cancer Res"},{"key":"3717_CR3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/cncr.10739","volume":"95","author":"SK Lutgendorf","year":"2002","unstructured":"Lutgendorf SK, Johnsen EL, Cooper B, Anderson B, Sorosky JI, Buller RE, Sood AK: Vascular endothelial growth factor and social support in patients with ovarian carcinoma. Cancer. 2002, 95: 808-815. 10.1002\/cncr.10739.","journal-title":"Cancer"},{"key":"3717_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1158\/1078-0432.CCR-05-1698","volume":"12","author":"AK Sood","year":"2006","unstructured":"Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S, Cole SW: Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res. 2006, 12: 369-375. 10.1158\/1078-0432.CCR-05-1698.","journal-title":"Clin Cancer Res"},{"key":"3717_CR5","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.yexcr.2005.11.022","volume":"312","author":"R Roy","year":"2006","unstructured":"Roy R, Zhang B, Moses MA: Making the cut: protease-mediated regulation of angiogenesis. Exp Cell Res. 2006, 312: 608-622. 10.1016\/j.yexcr.2005.11.022.","journal-title":"Exp Cell Res"},{"key":"3717_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cardiores.2004.12.002","volume":"65","author":"T Tammela","year":"2005","unstructured":"Tammela T, Enholm B, Alitalo K, Paavonen K: The biology of vascular endothelial growth factors. Cardiovasc Res. 2005, 65: 550-563. 10.1016\/j.cardiores.2004.12.002.","journal-title":"Cardiovasc Res"},{"key":"3717_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1385\/MO:22:3:241","volume":"22","author":"F Tas","year":"2005","unstructured":"Tas F, Oguz H, Argon A, Duranyildiz D, Camlica H, Yasasever V, Topuz E: The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma. Med Oncol. 2005, 22: 241-246. 10.1385\/MO:22:3:241.","journal-title":"Med Oncol"},{"key":"3717_CR8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1200\/JCO.2001.19.2.577","volume":"19","author":"S Ugurel","year":"2001","unstructured":"Ugurel S, Rappl G, Tilgen W, Reinhold U: Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J Clin Oncol. 2001, 19: 577-583.","journal-title":"J Clin Oncol"},{"key":"3717_CR9","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1158\/1055-9965.EPI-11-0249","volume":"20","author":"S Lemeshow","year":"2011","unstructured":"Lemeshow S, Sorensen HT, Phillips G, Yang EV, Antonsen S, Riis AH, Lesinski GB, Jackson R, Glaser R: \u00df-blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. Cancer Epidemiol Biomarkers Prev. 2011, 20: 2273-2279. 10.1158\/1055-9965.EPI-11-0249.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3717_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ygyno.2012.07.102","volume":"127","author":"ES Diaz","year":"2012","unstructured":"Diaz ES, Karlan BY, Li AJ: Impact of beta blockers on epithelial ovarian cancer survival. Gynecol Oncol. 2012, 127: 375-378. 10.1016\/j.ygyno.2012.07.102.","journal-title":"Gynecol Oncol"},{"key":"3717_CR11","unstructured":"Danish Medicines Agency: Information on over-the-counter medicine and reimbursement criteria in Denmark. Available from URL: http:\/\/laegemiddelstyrelsen.dk\/en\/ [accessed August 22, 2012]"},{"key":"3717_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/CLEP.S13458","volume":"2","author":"V Ehrenstein","year":"2010","unstructured":"Ehrenstein V, Antonsen S, Pedersen L: Existing data sources for clinical epidemiology: Aarhus University Prescription Database. Clin Epidemiol. 2010, 2: 273-279.","journal-title":"Clin Epidemiol"},{"key":"3717_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","volume":"39","author":"CB Pedersen","year":"2011","unstructured":"Pedersen CB: The Danish civil registration system. Scand J Public Health. 2011, 39: 22-25. 10.1177\/1403494810387965.","journal-title":"Scand J Public Health"},{"key":"3717_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1403494810393562","volume":"39","author":"ML Gjerstorff","year":"2011","unstructured":"Gjerstorff ML: The Danish Cancer Registry. Scand J Public Health. 2011, 39: 42-45. 10.1177\/1403494810393562.","journal-title":"Scand J Public Health"},{"key":"3717_CR15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/aje\/kwm324","volume":"167","author":"S Suissa","year":"2008","unstructured":"Suissa S: Immortal time bias in pharmaco-epidemiology. Am J Epidemiol. 2008, 167: 492-499. 10.1093\/aje\/kwm324.","journal-title":"Am J Epidemiol"},{"key":"3717_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1403494811401482","volume":"39","author":"E Lynge","year":"2011","unstructured":"Lynge E, Sandegaard JL, Rebolj M: The Danish National Patient Register. Scand J Public Health. 2011, 39: 30-33. 10.1177\/1403494811401482.","journal-title":"Scand J Public Health"},{"key":"3717_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40: 373-383. 10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"key":"3717_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jcrc.2004.09.007","volume":"20","author":"DM Needham","year":"2005","unstructured":"Needham DM, Scales DC, Laupacis A, Pronovost PJ: A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care. 2005, 20: 12-19. 10.1016\/j.jcrc.2004.09.007.","journal-title":"J Crit Care"},{"key":"3717_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2288-11-83","volume":"11","author":"SK Thygesen","year":"2011","unstructured":"Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT: The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011, 11: 83-10.1186\/1471-2288-11-83.","journal-title":"BMC Med Res Methodol"},{"key":"3717_CR20","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ejcts.2005.06.046","volume":"28","author":"O Birim","year":"2005","unstructured":"Birim O, Kappetein AP, Bogers AJ: Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg. 2005, 28: 759-762. 10.1016\/j.ejcts.2005.06.046.","journal-title":"Eur J Cardiothorac Surg"},{"key":"3717_CR21","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/00005537-199711000-00009","volume":"107","author":"B Singh","year":"1997","unstructured":"Singh B, Bhaya M, Stern J, Roland JT, Zimbler M, Rosenfeld RM, Har-El G, Lucente FE: Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study. Laryngoscope. 1997, 107: 1469-1475. 10.1097\/00005537-199711000-00009.","journal-title":"Laryngoscope"},{"key":"3717_CR22","doi-asserted-by":"publisher","first-page":"9524","DOI":"10.1073\/pnas.86.23.9524","volume":"86","author":"R Glaser","year":"1989","unstructured":"Glaser R, Zhang HY, Yao KT, Zhu HC, Wang FX, Li GY, Wen DS, Li YP: Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci USA. 1989, 86: 9524-9528. 10.1073\/pnas.86.23.9524.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3717_CR23","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.bbi.2007.09.010","volume":"22","author":"EV Yang","year":"2008","unstructured":"Yang EV, Donovan EL, Benson DM, Glaser R: VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine. Brain Behav Immun. 2008, 22: 318-323. 10.1016\/j.bbi.2007.09.010.","journal-title":"Brain Behav Immun"},{"key":"3717_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bbi.2008.10.005","volume":"23","author":"EV Yang","year":"2009","unstructured":"Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC, Webster Marketon JI, Barsky SH, Glaser R: Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun. 2009, 23: 267-275. 10.1016\/j.bbi.2008.10.005.","journal-title":"Brain Behav Immun"},{"key":"3717_CR25","doi-asserted-by":"publisher","first-page":"10357","DOI":"10.1158\/0008-5472.CAN-06-2496","volume":"66","author":"EV Yang","year":"2006","unstructured":"Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE: Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res. 2006, 66: 10357-10364. 10.1158\/0008-5472.CAN-06-2496.","journal-title":"Cancer Res"},{"key":"3717_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1470-2045(10)70260-6","volume":"12","author":"S Bangalore","year":"2011","unstructured":"Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, Gupta AK, Sever PS, Gluud C, Messerli FH: Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol. 2011, 12: 65-82. 10.1016\/S1470-2045(10)70260-6.","journal-title":"Lancet Oncol"},{"key":"3717_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/ije\/17.1.44","volume":"17","author":"HH Storm","year":"1988","unstructured":"Storm HH: Completeness of cancer registration in Denmark 1943\u20131966 and efficacy of record linkage procedures. Int J Epidemiol. 1988, 17: 44-49. 10.1093\/ije\/17.1.44.","journal-title":"Int J Epidemiol"},{"key":"3717_CR28","first-page":"535","volume":"44","author":"HH Storm","year":"1997","unstructured":"Storm HH, Michelsen EV, Clemmensen IH, Pihl J: The Danish Cancer Registry \u2013 history, content, quality and use. Dan Med Bull. 1997, 44: 535-539.","journal-title":"Dan Med Bull"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-85.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-85\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-85","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T04:05:44Z","timestamp":1498017944000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-85"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,22]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3717"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-85","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,22]]},"article-number":"85"}}